Track A: Analytical Development

Time: 9:00 am
day: Track A - Focus Day AM


The dramatic success of mRNA-based vaccines has marked a major milestone
for a previously unproven mRNA technology. As this industry continues to make
significant advances and brings effective therapies to patients, interests turn to
optimizing analytical and bioanalytical mRNA characterization to better assess
drug product or drug substance quality and efficacy. This focus day will deepdive into all-important considerations, successes, and challenges to spark the
conversation between peers, all striving to develop safe, stable and effective mRNA
therapeutics and vaccines.